Nanotechnology-based Drug Delivery Systems in Surgery:

A Convergence of Pharmacy and Surgical Science

 

Sarthak Perwal

MBBS, Guntur Medical College, 1st Year, Orthopedics Resident, Guntur, Andhra Pradesh, India.

*Corresponding Author E-mail: perwalsarthak@gmail.com

 

Abstract:

Nanotechnology has revolutionized drug delivery in surgical sciences by enabling precise, localized, and controlled pharmacological action. Conventional systemic administration often fails to achieve adequate drug concentrations at the surgical site, leading to infection, inflammation, or impaired healing. Nanoparticle-based carriers—liposomes, polymeric nanoparticles, dendrimers, and metallic nanostructures—offer site-specific delivery, improved bioavailability, and sustained release profiles. In surgery, nanotechnology-based systems have shown promise in reducing surgical site infections, promoting wound healing, minimizing implant rejection, and delivering chemotherapeutics directly to tumor resection margins. This review highlights current advancements, clinical applications, and future directions for nanotechnology-driven drug delivery in surgery, emphasizing its role in integrating pharmacy with operative science.

 

KEYWORDS: Nanotechnology, Drug, Delivery, Liposomes, Tumor, Pharmacy.

 

 


INTRODUCTION:

The intersection of nanotechnology, pharmacy, and surgery has opened new possibilities for targeted drug delivery. Conventional perioperative pharmacotherapy relies on systemic administration of antimicrobials, analgesics, and anti-inflammatory agents, but these approaches often suffer from low local concentrations and systemic toxicity. Nanotechnology enables precise control of drug release kinetics, enhanced tissue penetration, and targeted action at the surgical site. Such integration not only improves surgical outcomes but also minimizes complications and reduces healthcare costs.1,2

 

Nanoparticle Platforms in Surgery:

Liposomes: Liposomes encapsulate hydrophilic and hydrophobic drugs within lipid bilayers, providing controlled release at wound or implant sites. Liposomal amphotericin B and liposomal bupivacaine have been adapted for perioperative infection prevention and analgesia.3

 

Polymeric Nanoparticles: Biodegradable polymers such as polylactic-co-glycolic acid (PLGA) allow incorporation of antibiotics, growth factors, and anti-cancer agents. These nanoparticles can be embedded in surgical sutures, meshes, and implants for sustained local release.4

 

Metallic Nanoparticles: Silver, gold, and zinc oxide nanoparticles exhibit inherent antimicrobial properties. Silver nanoparticles incorporated into surgical dressings and implant coatings reduce infection rates without significant systemic absorption.5

 

Dendrimers and Nanogels: Dendrimers, with their branched architecture, allow high drug-loading capacity, while nanogels provide a hydrophilic network suitable for controlled release of peptides, proteins, and nucleic acids in surgical oncology.6

 

Clinical Applications in Surgery:

Infection Control:

Postoperative infections are a major cause of morbidity. Nanoparticle-based coatings on implants and sutures elute antimicrobial agents directly at the site, minimizing bacterial colonization and biofilm formation.7

 

Wound Healing:

Nanofiber scaffolds loaded with growth factors or siRNA facilitate angiogenesis and fibroblast proliferation, accelerating tissue regeneration in complex wounds.8

 

Surgical Oncology:

Nanoparticles delivering chemotherapeutics such as doxorubicin or cisplatin to tumor beds post-resection have demonstrated enhanced local cytotoxicity with reduced systemic toxicity. Magnetic nanoparticles also enable hyperthermic ablation of residual cancer cells.9

 

Orthopaedic and Dental Surgery:

Drug-loaded nanocoatings on titanium and ceramic implants improve osteointegration while reducing infection and inflammation, enhancing long-term implant survival.10

 

Future Perspectives:

Nanotechnology-Based Drug Delivery in Surgery is Poised to Expand with:

Stimuli-responsive systems releasing drugs in response to pH, temperature, or enzymatic activity at surgical sites.

3D-printed nanomaterials that integrate surgical implants with embedded drug reservoirs.

Personalized nanomedicine guided by pharmacogenomics, tailoring nanosystems to individual patient needs.

Smart nanosensors integrated into implants for real-time monitoring of infection, healing, and drug release.

 

CONCLUSION:

Nanotechnology-based drug delivery systems embody the convergence of pharmacy and surgical science. By enabling controlled, site-specific drug action, these systems reduce complications, accelerate recovery, and enhance precision in surgical practice. Future research will focus on bio-responsive materials, regulatory approvals, and clinical translation, ensuring nanomedicine becomes integral to operative care.

 

REFERENCES:

1.        Langer R, Weissleder R. Nanotechnology in the clinic: An introduction. N Engl J Med. 2015;373(20):1977–9.

2.        Ventola CL. The nanomedicine revolution: Part 1. Emerging concepts. P T. 2012;37(9):512–25.

3.        Barratt G. Liposomes for drug delivery in surgery. Adv Drug Deliv Rev. 2003;55(12):1603–19.

4.        Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: A review of biomedical applications. J Control Release. 2012;161(2):505–22.

5.        Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83.

6.        Boas U, Heegaard PM. Dendrimers in drug research. Chem Soc Rev. 2004;33(1):43–63.

7.        Campoccia D, Montanaro L, Arciola CR. Antimicrobial coatings on medical implants: Methods and applications. Biomaterials. 2013;34(33):8018–29.

8.        Augustine R, Hasan A, Patan NK, Dalvi YB, Varghese R, Antony A, et al. Nanotechnology-based drug delivery for wound healing: Recent advances and future prospects. Adv Drug Deliv Rev. 2021;172:148–73.

9.        Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Acc Chem Res. 2011;44(10):1050–60.

10.      Kaur P, Gondil VS, Chhibber S, Sharma S, Kumar M, Kataria R, et al. Nanoengineered surfaces for orthopedic and dental implants: Advances and prospects. Mater Sci Eng C Mater Biol Appl. 2019;103:109770.

 

 

Received on 03.10.2025      Revised on 07.04.2026

Accepted on 10.07.2026      Published on 19.10.2026

Available online from October 31, 2026

Research J. Science and Tech. 2026; 18(4):367-368.

DOI: 10.52711/2349-2988.2026.00051

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.